Biotoxtech (Korea) Performance
| 086040 Stock | KRW 5,600 50.00 0.88% |
The firm shows a Beta (market volatility) of -0.42, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Biotoxtech are expected to decrease at a much lower rate. During the bear market, Biotoxtech is likely to outperform the market. Biotoxtech has an expected return of -0.0691%. Please make sure to confirm Biotoxtech total risk alpha, maximum drawdown, and the relationship between the jensen alpha and treynor ratio , to decide if Biotoxtech performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Biotoxtech Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Biotoxtech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -7.8 B |
Biotoxtech |
Biotoxtech Relative Risk vs. Return Landscape
If you would invest 595,000 in Biotoxtech Co on February 1, 2024 and sell it today you would lose (35,000) from holding Biotoxtech Co or give up 5.88% of portfolio value over 90 days. Biotoxtech Co is generating negative expected returns and assumes 2.6066% volatility on return distribution over the 90 days horizon. Simply put, 23% of stocks are less volatile than Biotoxtech, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Biotoxtech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotoxtech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biotoxtech Co, and traders can use it to determine the average amount a Biotoxtech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0265
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 086040 |
Estimated Market Risk
| 2.61 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Biotoxtech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biotoxtech by adding Biotoxtech to a well-diversified portfolio.
Biotoxtech Fundamentals Growth
Biotoxtech Stock prices reflect investors' perceptions of the future prospects and financial health of Biotoxtech, and Biotoxtech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biotoxtech Stock performance.
| Return On Equity | 13.27 | |||
| Return On Asset | 0.0343 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 156.1 B | |||
| Shares Outstanding | 14.56 M | |||
| Price To Earning | 47.60 X | |||
| Price To Sales | 3.12 X | |||
| Revenue | 34.09 B | |||
| EBITDA | 5.67 B | |||
| Cash And Equivalents | 18.59 B | |||
| Cash Per Share | 803.72 X | |||
| Total Debt | 2.01 B | |||
| Debt To Equity | 47.30 % | |||
| Book Value Per Share | 1,604 X | |||
| Cash Flow From Operations | 4.35 B | |||
| Total Asset | 90.74 B | |||
| Retained Earnings | (4.82 B) | |||
| Current Asset | 13.46 B | |||
| Current Liabilities | 18.21 B | |||
About Biotoxtech Performance
To evaluate Biotoxtech Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Biotoxtech generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Biotoxtech Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Biotoxtech market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Biotoxtech's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Biotoxtech Co., Ltd. engages in the safety evaluation of pharmaceuticals, foods, cosmetics, cell therapeutics, chemicals, agrochemicals, and medical equipment in South Korea. Biotoxtech Co., Ltd. was founded in 2000 and is headquartered in Cheongwon, South Korea. Biotoxtech is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Biotoxtech performance evaluation
Checking the ongoing alerts about Biotoxtech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biotoxtech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biotoxtech generated a negative expected return over the last 90 days | |
| The company has accumulated 2.01 B in total debt with debt to equity ratio (D/E) of 47.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Biotoxtech has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Biotoxtech until it has trouble settling it off, either with new capital or with free cash flow. So, Biotoxtech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biotoxtech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biotoxtech to invest in growth at high rates of return. When we think about Biotoxtech's use of debt, we should always consider it together with cash and equity. | |
| About 27.0% of Biotoxtech shares are owned by insiders or employees |
- Analyzing Biotoxtech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biotoxtech's stock is overvalued or undervalued compared to its peers.
- Examining Biotoxtech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biotoxtech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biotoxtech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biotoxtech's stock. These opinions can provide insight into Biotoxtech's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotoxtech Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Biotoxtech information on this page should be used as a complementary analysis to other Biotoxtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Biotoxtech Stock analysis
When running Biotoxtech's price analysis, check to measure Biotoxtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotoxtech is operating at the current time. Most of Biotoxtech's value examination focuses on studying past and present price action to predict the probability of Biotoxtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotoxtech's price. Additionally, you may evaluate how the addition of Biotoxtech to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Directory Find actively traded commodities issued by global exchanges |